In Vivo Pharmacodynamics of HMR 3270, a Glucan Synthase Inhibitor, in a Murine Candidiasis Model

In vivo pharmacokinetic/pharmacodynamic characterization for numerous antibacterial compounds has had a significant impact upon optimal dosing regimen design and the development of in vivo susceptibility breakpoints. More recently, similar characterization has been undertaken for antifungal drug cla...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Andes, D., Marchillo, K., Lowther, J., Bryskier, A., Stamstad, T., Conklin, R.
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 2003
Sujets:	Experimental Therapeutics
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC152480/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12654645/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.4.1187-1192.2003
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!